John Overdeck’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Sell
230,625
-28,435
-11% -$271K ﹤0.01% 2926
2026
Q1
$2.37M Sell
259,060
-9,773
-4% -$82K ﹤0.01% 2625
2025
Q4
$2M Buy
268,833
+63,807
+31% +$459K ﹤0.01% 2428
2025
Q3
$1.37M Buy
+205,026
New +$1.42M ﹤0.01% 2375
2025
Q2
Sell
-35,572
Closed -$325K 3204
2025
Q1
$325K Buy
35,572
+12
+0% +$120 ﹤0.01% 2682
2024
Q4
$373K Sell
35,560
-7,197
-17% -$85.1K ﹤0.01% 2663
2024
Q3
$511K Sell
42,757
-60,048
-58% -$519K ﹤0.01% 2466
2024
Q2
$591K Sell
102,805
-2,875
-3% -$15.8K ﹤0.01% 2288
2024
Q1
$550K Buy
105,680
+20,722
+24% +$101K ﹤0.01% 2291
2023
Q4
$448K Buy
84,958
+23,243
+38% +$92K ﹤0.01% 2515
2023
Q3
$204K Buy
61,715
+5,155
+9% +$18.1K ﹤0.01% 2635
2023
Q2
$163K Sell
56,560
-73,754
-57% -$142K ﹤0.01% 2683
2023
Q1
$139K Buy
130,314
+101,805
+357% +$195K ﹤0.01% 2625
2022
Q4
$74.4K Buy
+28,509
New +$124K ﹤0.01% 2545
2021
Q4
Sell
-32,279
Closed -$457K 4316
2021
Q3
$457K Buy
+32,279
New +$497K ﹤0.01% 3343

Other funds holding BVS

John Overdeck's BVS Position: Q2 2026 in Review

John Overdeck reduced its Bioventus (BVS) stake by 11% in Q2 2026, selling an estimated $271K and leaving 230,625 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

John Overdeck first reported a position in BVS in Q3 2021 and has held it in 15 quarters since. The position peaked at $2.37M in Q1 2026. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • John Overdeck held 230,625 shares of Bioventus worth $2.18M as of Q2 2026.
  • John Overdeck sold 28,435 Bioventus shares in Q2 2026, an estimated $271K.
  • Bioventus made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2926 holding.
  • John Overdeck first reported a position in Bioventus in Q3 2021 and has held it in 15 quarters since.
  • John Overdeck's Bioventus position peaked at $2.37M in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.